Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors

Details for Australian Patent Application No. 2004238512 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Cheung, Adrian Wai-Hing; Thakkar, Kshitij Chhabilbhai; Yun, Weiya; Kim, Kyungjin; Berthel, Steven Joseph

Agent Spruson & Ferguson

Pub. Number AU-B-2004238512

PCT Pub. Number WO2004/101568

Priority 60/470,803 15.05.03 US; 60/563,584 19.04.04 US

Filing date 7 May 2004

Wipo publication date 25 November 2004

Acceptance publication date 19 July 2007

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 5/50 (2006.01) Drugs for disorders of the endocrine system

Event Publications

24 November 2005 PCT application entered the National Phase

  PCT publication WO2004/101568 Priority application(s): WO2004/101568

19 July 2007 Application Accepted

  Published as AU-B-2004238512

15 November 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004238514-Method for producing a cast metal strip and corresponding twin roll casting installation

2004238508-Imidazo-benzothiazoles